These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3122115)
1. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months. Bignardi L; Neild GH; Hartley RB; Taube DH; Cameron JS; Rudge CJ; Williams DG; Ogg CS Nephrol Dial Transplant; 1987; 2(5):366-70. PubMed ID: 3122115 [TBL] [Abstract][Full Text] [Related]
2. Kidney biopsies in control or cyclosporin A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporin A (Sandimmun) in Autoimmune Diseases. Br J Dermatol; 1990 Jun; 122 Suppl 36():95-100. PubMed ID: 2369573 [TBL] [Abstract][Full Text] [Related]
3. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation]. Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937 [TBL] [Abstract][Full Text] [Related]
4. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients? Ubhi CS; Woodhouse L; Guillou PJ; Giles GR Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426 [TBL] [Abstract][Full Text] [Related]
5. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop. Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437 [TBL] [Abstract][Full Text] [Related]
6. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation. Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858 [TBL] [Abstract][Full Text] [Related]
7. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression. Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy. Häyry P; von Willebrand E; Ahonen J Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749 [TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. Murphy GJ; Waller JR; Sandford RS; Furness PN; Nicholson ML Br J Surg; 2003 Jun; 90(6):680-6. PubMed ID: 12808614 [TBL] [Abstract][Full Text] [Related]
11. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Dimény E; Wahlberg J; Larsson E; Fellström B Clin Transplant; 1995 Apr; 9(2):79-84. PubMed ID: 7599406 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study. Clasen W; Kindler J; Mihatsch MJ; Sieberth HG Nephrol Dial Transplant; 1988; 3(6):733-7. PubMed ID: 3147414 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
14. Renal allograft histology and correlation with function in children on triple therapy. Laine J; Krogerus L; Jalanko H; Rönnholm K; Holmberg C Nephrol Dial Transplant; 1995; 10(1):95-102. PubMed ID: 7724039 [TBL] [Abstract][Full Text] [Related]
15. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. Svenson K; Bohman SO; Hällgren R Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545 [TBL] [Abstract][Full Text] [Related]
16. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection. Brook NR; White SA; Waller JR; Bicknell GR; Nicholson ML Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557 [TBL] [Abstract][Full Text] [Related]
17. [Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C]. Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Tkaczuk J; Durand D; Suc JM Nephrologie; 1996; 17(4):247-54. PubMed ID: 8768457 [TBL] [Abstract][Full Text] [Related]
18. Optimal cyclosporin levels during the first month after cadaveric kidney transplantation. Leuven Collaborative Group for Transplantation. Vanrenterghem Y; Waer M; Roels L; Michielsen P Transplant Proc; 1989 Feb; 21(1 Pt 2):1467-8. PubMed ID: 2652469 [No Abstract] [Full Text] [Related]
19. A brief review of histopathology in kidney transplant recipients immunosuppressed with cyclosporin A. Mihatsch MJ Scand J Urol Nephrol Suppl; 1985; 92():95-7. PubMed ID: 3914070 [TBL] [Abstract][Full Text] [Related]